GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » IMBdx Inc (XKRX:461030) » Definitions » Total Tax Payable

IMBdx (XKRX:461030) Total Tax Payable : ₩0 Mil (As of Dec. 2024)


View and export this data going back to 2024. Start your Free Trial

What is IMBdx Total Tax Payable?

IMBdx's Total Tax Payable for the quarter that ended in Dec. 2024 was ₩0 Mil.


IMBdx Total Tax Payable Historical Data

The historical data trend for IMBdx's Total Tax Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

IMBdx Total Tax Payable Chart

IMBdx Annual Data
Trend Dec21 Dec22 Dec23 Dec24
Total Tax Payable
- - - -

IMBdx Quarterly Data
Dec21 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Total Tax Payable Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

IMBdx Total Tax Payable Calculation

Total Tax Payable is the taxes liability owed to federal, state, and local tax authorities. It is the carrying value as of the balance sheet date of obligations incurred and payable for statutory income, sales, use, payroll, excise, real, property and other taxes.


IMBdx Total Tax Payable Related Terms

Thank you for viewing the detailed overview of IMBdx's Total Tax Payable provided by GuruFocus.com. Please click on the following links to see related term pages.


IMBdx Business Description

Traded in Other Exchanges
N/A
Address
131 Gasandigital 1-ro, 21st Floor BYC Highcity Building A, Geumcheon-gu, Seoul, KOR, 08506
IMBdx Inc detects and analyzes the genomic profile of tumor DNA with a single draw of blood. It provides personalized and optimized analysis information that can be utilized in therapy selection and monitoring. Its AlphaLiquid platform offers ctDNA-based precision diagnostics solutions across the full continuum of cancer care, from therapy selection (AlphaLiquid 100/HRR) to recurrence and minimal residual disease(MRD) monitoring (CancerDetect), and multi-cancer early detection (CancerFind). Its services are Clinical Service BioPharma, Research, and Healthcare Checkup.

IMBdx Headlines

No Headlines